RUA Life Sciences plc (RUA.L) LSE

Currency In GBp

AD

Valuation

Market Cap7.76M
Enterprise Value7.76M
P/E Ratio-91.3
PEG Ratio0.71
Price/Sales Ratio2.92
Price/Book Ratio1.82
Enterprise/Revenue2.37
Enterprise/EBITDA-27.59

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.03
Operating Margin-0.19
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.02

Income Statement

Revenue4.46M
Revenue/Share0.07
Gross Profit3.06M
EBITDA-383,335
Net Income-145,334
Diluted EPS-0

Balance Sheet

Total Cash3.25M
Total Cash/Share0.05
Total Debt794,000
Total Debt/Equity0.11
Current Ratio4.64
Book Value Per Share0.12

Price History

52-Week Change68
52-Week High31
52-Week Low11.5
Moving Average 50 Days27.8
Moving Average 200 Days21.34

Statistics

Average Volume160,792
Shares Outstanding62.06M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateSeptember 01, 2003
AD